JPWO2021133829A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021133829A5
JPWO2021133829A5 JP2022538726A JP2022538726A JPWO2021133829A5 JP WO2021133829 A5 JPWO2021133829 A5 JP WO2021133829A5 JP 2022538726 A JP2022538726 A JP 2022538726A JP 2022538726 A JP2022538726 A JP 2022538726A JP WO2021133829 A5 JPWO2021133829 A5 JP WO2021133829A5
Authority
JP
Japan
Prior art keywords
cas12l
polypeptide
guide rna
nucleic acid
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022538726A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023508362A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/066672 external-priority patent/WO2021133829A1/en
Publication of JP2023508362A publication Critical patent/JP2023508362A/ja
Publication of JPWO2021133829A5 publication Critical patent/JPWO2021133829A5/ja
Pending legal-status Critical Current

Links

JP2022538726A 2019-12-23 2020-12-22 Crispr-casエフェクターポリペプチド及びその使用方法 Pending JP2023508362A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962952909P 2019-12-23 2019-12-23
US62/952,909 2019-12-23
PCT/US2020/066672 WO2021133829A1 (en) 2019-12-23 2020-12-22 Crispr-cas effector polypeptides and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023508362A JP2023508362A (ja) 2023-03-02
JPWO2021133829A5 true JPWO2021133829A5 (pt) 2023-12-01

Family

ID=76573115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022538726A Pending JP2023508362A (ja) 2019-12-23 2020-12-22 Crispr-casエフェクターポリペプチド及びその使用方法

Country Status (11)

Country Link
US (1) US20230028178A1 (pt)
EP (1) EP4081533A4 (pt)
JP (1) JP2023508362A (pt)
KR (1) KR20220130686A (pt)
CN (1) CN115698041A (pt)
AU (1) AU2020412714A1 (pt)
BR (1) BR112022009670A2 (pt)
CA (1) CA3158403A1 (pt)
IL (1) IL292896A (pt)
MX (1) MX2022007858A (pt)
WO (1) WO2021133829A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112023024985A2 (pt) 2021-06-01 2024-02-20 Arbor Biotechnologies Inc Sistemas de edição de genes compreendendo uma crispr nuclease e usos dos mesmos
EP4373963A2 (en) 2021-07-21 2024-05-29 Montana State University Nucleic acid detection using type iii crispr complex
WO2023039346A1 (en) * 2021-09-10 2023-03-16 The Regents Of The University Of California Temperature regulated crispr-cas systems and methods of use thereof
WO2023240157A2 (en) 2022-06-08 2023-12-14 Scribe Therapeutics Inc. Compositions and methods for the targeting of dmd
WO2023250384A2 (en) * 2022-06-22 2023-12-28 The Regents Of The University Of California Crispr-cas effector polypeptides and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2072527A1 (en) * 2007-12-21 2009-06-24 Altonabiotec AG Fusion polypeptides comprising a SHBG dimerization component and uses thereof
RU2721275C2 (ru) * 2012-12-12 2020-05-18 Те Брод Инститьют, Инк. Доставка, конструирование и оптимизация систем, способов и композиций для манипуляции с последовательностями и применения в терапии
DK3597740T3 (da) * 2014-11-06 2022-06-20 Dupont Us Holding Llc Peptidmedieret indføring af rna-styret endonuklease i celler
KR20230170126A (ko) * 2016-09-30 2023-12-18 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Rna-가이드된 핵산 변형 효소 및 이의 사용 방법
GB2569734B (en) * 2016-09-30 2022-09-07 Univ California RNA-guided nucleic acid modifying enzymes and methods of use thereof
US20200255858A1 (en) * 2017-11-01 2020-08-13 Jillian F. Banfield Casy compositions and methods of use
US10253365B1 (en) * 2017-11-22 2019-04-09 The Regents Of The University Of California Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
US20220282308A1 (en) * 2019-09-09 2022-09-08 Arbor Biotechnologies, Inc. Novel crispr dna targeting enzymes and systems

Similar Documents

Publication Publication Date Title
Polidoros et al. Rolling circle amplification-RACE: a method for simultaneous isolation of 5′ and 3′ cDNA ends from amplified cDNA templates
Zhu et al. Syn5 RNA polymerase synthesizes precise run-off RNA products
US9255291B2 (en) Oligonucleotide ligation methods for improving data quality and throughput using massively parallel sequencing
JP7292258B2 (ja) 縦列反復配列を有するドナーdna修復鋳型を使用する部位特異的なdna改変
US11761037B1 (en) Probe and method of enriching target region applicable to high-throughput sequencing using the same
EA038500B1 (ru) Термостабильные нуклеазы cas9
JP2022111117A5 (pt)
CN102301010A (zh) 闭合线状dna的制备
US11401543B2 (en) Methods and compositions for improving removal of ribosomal RNA from biological samples
JP5200302B2 (ja) ヘリカーゼを使用するrnaターゲットの同定
JP6583796B2 (ja) 核酸の増幅方法
Liu et al. Capping-RACE: a simple, accurate, and sensitive 5′ RACE method for use in prokaryotes
WO2023246032A1 (zh) 一锅法单链DNA环化扩增和CRISPR/Cas介导的核酸分子检测方法
US10858694B2 (en) Methods and reagents for reverse-transcription polymerase chain reaction
US20240200047A1 (en) Enzymes with ruvc domains
JPWO2021133829A5 (pt)
CN114391043B (zh) 哺乳动物dna的甲基化检测及分析
WO2023093060A1 (zh) 基于重组酶聚合酶扩增技术的逆转录扩增系统和方法
CN104059905B (zh) 室温扩增dna的方法
Fujii et al. Error-prone rolling circle amplification greatly simplifies random mutagenesis
Takahashi et al. Cell-free cloning using multiply-primed rolling circle amplification with modified RNA primers
JP2017534297A (ja) トランスポゼースによる核酸の切断及びリンカー付加の方法及び試薬
Kirsch et al. A streamlined protocol for the detection of mRNA–sRNA interactions using AMT-crosslinking in vitro
CN111850100A (zh) 核酸扩增方法及其应用
JPWO2021050755A5 (pt)